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FEBS Letters 586 (2012) 2802journal homepage: www.FEBSLetters .orgFEBS Letters Young Group Leader Award 2012The FEBS Letters Young Group Leader Award is given to an inde-
pendent scientist, aged 40 years or younger, who is the corre-
sponding author of an outstanding research letter published in
the previous calendar year. The prize is endowed with €10.000
prize money and is presented on the annual FEBS Congress.
2012 FEBS Letters Young Group Leader Award Winner:Dr. Megumi Funakoshi-Tago
Keio University
The award winning manuscript is:
Sumi K, Tago K, Kasahara T, Funakoshi-Tago M (2011) Aurora
kinase. A critically contributes to the resistance to anti-cancer drug
cisplatin in JAK2 V617F mutant-induced transformed cells. FEBS
Lett. 585(12):1884–90.
The prize-winning manuscript investigates the mechanisms by
which cancer cells survive chemotherapeutic drugs. In particular,
the authors address how JAK2, a non-receptor tyrosine kinase oftenhttp://dx.doi.org/10.1016/j.febslet.2012.07.039deregulated in hematological malignancies, contributes to che-
moresistance. It was previously reported that JAK2 upregulates
several transcription factors, including Myc. The group led by Dr.
Funakoshi-Tago now shows the critical requirement of Myc-in-
duced Aurora kinase A for the resistance of cells expressing an on-
cogenic mutant of JAK2 to cisplatin, a commonly used anticancer
drug. These results provide insight into the intricate ways tumor
cells exploit signalling pathways and suggest that the combination
of Aurora kinase inhibitors with chemotherapeutic drugs may be
useful to treat myeloproliferative neoplasms.
The Award Committee were: Angel Nebreda (Barcelona) Chair,
Pascale Zimmermann (Marseille and Leuven), Maurice Montal
(San Diego) and Laszlo Nagy (Debrecen). We would like to thank
them for selecting the prize winner.
Dr. Megumi Funakoshi-Tago will give a plenary lecture about
her work at the 37th FEBS/22nd IUBMB Congress in Seville, where
she will be ofﬁcially presented with the prize.
If you would like to be considered for the FEBS Letters award,
submit a research letter to us before your 41st birthday: http://
ees.elsevier.com/febsletters.
